HERCONNECTION
Live / Registered — Registered (as of 30 Jan 2024)
What this means for you
Registered since 30 Jan 2024. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 30 Jan 2030: the §8 declaration of use).
Record
- Serial number
- 97524627
- Registration number
- 7293010
- Mark type
- Word mark
- Filed
- 28 Jul 2022
- Published for opposition
- 14 Nov 2023
- Registered
- 30 Jan 2024
- Next maintenance filing
- §8 declaration of use, due by 30 Jan 2030 (grace period to 30 Jul 2030)
- Attorney of record
- Gregory Zinkl
Goods and services
- Class 036 — Insurance and financial services: Providing breast cancer patients with information on available financial support for breast cancer treatments
- Class 044 — Medical, beauty and agricultural services: Pharmaceutical patient support program providing health and treatment information, namely, disease management and treatment information to improve understanding by breast cancer patients about pharmaceutical treatments
Owner
- Genentech, Inc., SOUTH SAN FRANCISCO, CA, US
- Genentech, Inc., South San Francisco, CA, US
- Genentech, Inc., South San Francisco, CA, US
Prosecution history
- 09 Apr 2026 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 09 Apr 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 09 Apr 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 09 Apr 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 09 Apr 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 09 Apr 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 30 Jan 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 30 Jan 2024 — REGISTERED-PRINCIPAL REGISTER
- 14 Nov 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Nov 2023 — PUBLISHED FOR OPPOSITION
- 25 Oct 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Oct 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 04 Oct 2023 — EXAMINER'S AMENDMENT ENTERED
- 04 Oct 2023 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 04 Oct 2023 — EXAMINERS AMENDMENT E-MAILED